Highlights
Bharat Biotech has decided to ramp up its production of COVID-19 vaccine Covaxin to an additional 200 million doses per year.
The anti-COVID vaccine will be produced at Chiron Behring Vaccines, Ankleshwar in Gujarat.
The product will likely be available from Q4 2021.
New Delhi: Bharat Biotech, the company which manufactures COVID-19 vaccine Covaxin, has decided to ramp up its production to manufacture additional 200 million doses per year.
The COVID-19 vaccines will be produced at Chiron Behring Vaccines, Ankleshwar, Gujarat,
To this effect Bharat Biotech issued a statement saying: The company plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production of vaccines based on inactivated Vero Cell Platform Technology under stringent levels of GMP and biosafety. Product availability at Ankleshwar to commence from the fourth quarter of 2021.
New Delhi [India], May 20 (ANI): Amid the growing demand for vaccines in the country, Hyderabad-based Bharat Biotech has announced ramping up of additional manufacturing capacities for Covaxin at Chiron Behring Vaccines in Gujarat's Ankleshwar.
Bharat Biotech said on Thursday that production volumes have been ramped up by an additional 200 million doses at Ankleshwar, Gujarat. Product availability at Ankleshwar to commence from Q4 FY2022 (Jan-March). The company said the quick ramp up of additional manufacturing capacities for Covaxin was done at Chiron Behring Vaccines, Ankleshwar Gujarat, a wholly owned subsidiary of Bharat Biotech. The company plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production of vaccines based on Inactivated Vero Cell Platform Technology, under stringent levels of GMP and biosafety, it said. Dear Reader,
Bharat Biotech Gujarat arm to make Covaxin
Updated:
Updated:
Product availability from Oct-Dec quarter, 200 m doses a year to come on stream
Share Article
Product availability from Oct-Dec quarter, 200 m doses a year to come on stream
Covaxin maker Bharat Biotech on Thursday said it will start producing the vaccine at its Chiron Behring Vaccines unit in Ankleshwar, Gujarat, thereby adding 200 million doses of output per annum. The product is expected to be available from Q4 (October-December) of 2021.
Bharat Biotech said the Ankleshwar facility was already operational for vaccine production based on inactivated vero cell platform technology, under stringent levels of biosafety. The added output will take the volume of Covaxin production to about one billion doses per annum.
Bharat Biotech big statement Covaxin production to reach 1 billion doses per year covid vaccine latest news indiatvnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatvnews.com Daily Mail and Mail on Sunday newspapers.